Amphastar Pharmaceuticals, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

24.30$ -0.7% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

Amphastar Pharmaceuticals, Inc. (AMPH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 184 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement AMPH
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	181	178	172	182	189	187	171	174	192	183	171	184	730
Cost of Revenue	72	82	85	87	87	100	85	88	93	97	101	90	382
Gross Profit	108	96	87	95	102	87	85	86	99	86	70	93	348
Research & Development	17	20	14	18	21	18	20	20	22	23	27	22	95
Selling, General & Administrative	13	13	16	13	15	13	16	14	39	16	18	18	92
Total Operating Expenses	36	42	39	40	45	42	48	44	73	50	57	54	234
Operating Income	73	54	48	55	57	45	37	42	25	36	14	40	114
Interest Expense	14	9.5	8.6	8.6	6.7	6.4	6.3	6.3	6.3	6.6	6.6	6.7	26
Pre-Tax Income	63	41	47	50	48	44	31	39	22	32	10	39	102
Income Tax Expense	14	4.7	4.1	12	7.3	6.0	5.6	8.3	4.2	7.5	3.6	8.2	23
Net Income	49	36	43	38	40	38	25	31	17	24	6.4	30	79
EBITDA	91	65	70	73	69	65	52	62	42	55	33	45	175

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings